Post-COVID syndrome: an insight on its pathogenesis
Post-COVID syndrome is increasingly recognized as a new clinical entity in the context of
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …
SARS-CoV-2 infection. Symptoms persisting for more than three weeks after the diagnosis of …
[HTML][HTML] Remdesivir for the treatment of COVID‐19
F Grundeis, K Ansems, K Dahms… - … of systematic reviews, 2023 - ncbi.nlm.nih.gov
Background Remdesivir is an antiviral medicine approved for the treatment of mild‐to‐
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …
moderate coronavirus disease 2019 (COVID‐19). This led to widespread implementation …
Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review
NN Nguyen, VT Hoang, TL Dao, P Dudouet… - European Journal of …, 2022 - Springer
Background Long COVID-19 may affect patients after hospital discharge. Aims This study
aims to describe the burden of the long-term persistence of clinical symptoms in COVID-19 …
aims to describe the burden of the long-term persistence of clinical symptoms in COVID-19 …
Hypertension, a moving target in COVID-19: current views and perspectives
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …
coronavirus 2 (SARS-CoV-2) associates with a considerable high rate of mortality and …
The role of IL-6 and IL-6 blockade in COVID-19
N Potere, A Batticciotto, A Vecchié… - Expert review of …, 2021 - Taylor & Francis
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) induces a
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
dysregulated hyperinflammatory response. Areas covered Authors review evidence on IL-6 …
Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …
improved in terms of disease management and capacity is yet to be defined. Objective To …
Expression of ACE2, soluble ACE2, angiotensin I, angiotensin II and angiotensin-(1-7) is modulated in COVID-19 patients
The etiological agent of COVID-19 SARS-CoV-2, is primarily a pulmonary-tropic
coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the …
coronavirus. Infection of alveolar pneumocytes by SARS-CoV-2 requires virus binding to the …
Myocardial pathology in COVID-19-associated cardiac injury: a systematic review
A Maiese, P Frati, F Del Duca, P Santoro, AC Manetti… - Diagnostics, 2021 - mdpi.com
Coronavirus disease 2019 (COVID-19) can potentially affect all organs owing to the
ubiquitous diffusion of the angiotensin-converting enzyme II (ACE2) receptor-binding …
ubiquitous diffusion of the angiotensin-converting enzyme II (ACE2) receptor-binding …
[HTML][HTML] Spread of mink SARS-CoV-2 variants in humans: a model of sarbecovirus interspecies evolution
CA Devaux, L Pinault, J Delerce, A Levasseur… - Frontiers in …, 2021 - frontiersin.org
The rapid spread of SARS-CoV-2 variants has quickly spanned doubts and the fear about
their ability escape vaccine protection. Some of these variants initially identified in caged …
their ability escape vaccine protection. Some of these variants initially identified in caged …
Shared genetics and causal associations between COVID‐19 and multiple sclerosis
Neuroinflammation caused by COVID‐19 negatively impacts brain metabolism and function,
while pre‐existing brain pathology may contribute to individuals' vulnerability to the adverse …
while pre‐existing brain pathology may contribute to individuals' vulnerability to the adverse …